Late-stage success for experimental migraine drug

2nd January 2020 Uncategorised 0

The results support the filing of a New Drug Application (NDA) for Axsome’s AXS-07 in the acute treatment of migraine.

More: Late-stage success for experimental migraine drug
Source: News